Table 1.
Compound | IC50 (μM) | MIC99 (μM) | %Viability |
---|---|---|---|
T. vaginalis | H37Rv | HeLa Cells | |
5a | 15.3 ± 0.33 | 61.8 | 108.5 ± 5.35 |
5b | 41.7 ± 0.23 | 107 | 87.0 ± 1.59 |
5c | 10.2 ± 0.56 | 26.5 | 94.3 ± 28.8 |
5d | 12.6 ± 0.28 | 10.7 | 89.9 ± 5.12 |
5e | 11.7 ± 0.28 | 18.7 | 102.5 ± 2.34 |
5f | ˃50 | ˃125 | 109.9 ± 0.84 |
5g | 22.8 ± 1.02 | 40.7 | 131.5 ± 26.6 |
EM | - | - | 3.195 |
ME | 0.53 | - | - |
RE | - | 0.003 | - |
EM = emetine, ME = metronidazole, RE = rifampicin.